Table 1.
Baseline Characteristics of the Participants
| Controls (n=12) | PCOS (n=13) | P Value | |
|---|---|---|---|
| Age, y | 24.1±5.8 | 28.0±6.3 | 0.13 |
| Body mass index, kg/m2 | 25.5±5.0 | 29.7±6.0 | 0.07 |
| Waist, cm | 80.9±12.5 | 96.5±17 | 0.02 |
| Waist:hip ratio | 0.79±0.07 | 0.86±0.02 | 0.04 |
| Systolic blood pressure, mm Hg | 116±9 | 118±11 | 0.56 |
| Diastolic blood pressure, mm Hg | 74±9 | 75±8 | 0.73 |
| Testosterone, nmol/L | 1.03±0.34 | 1.51±0.77 | 0.05 |
| Free androgen index | 1.6±1.0 | 6.6±3.2 | <0.001 |
| Sex hormone binding globulin, nmol/L | 75±30 | 28±19 | <0.001 |
| Alanine aminotransferase, IU/L | 17±5 | 27±13 | 0.01 |
| Total cholesterol, mmol/L | 4.7±0.79 | 4.1±0.63 | 0.14 |
| Triglycerides, mmol/L | 0.96±0.32 | 1.12±0.51 | 0.35 |
| HDL‐c, mmol/L | 1.58±0.48 | 1.2±0.37 | 0.06 |
| LDL‐c, mmol/L | 2.31±0.49 | 2.68±0.58 | 0.10 |
| Fasting plasma glucose, mmol/L | 4.69±0.51 | 4.74±0.45 | 0.08 |
| HOMA‐IR | 1.33±0.69 | 2.50±1.5 | 0.03 |
| NEFA, mmol/L | 0.55 (0.33, 0.66) | 0.54 (0.35, 0.54) | 0.23 |
Results are expressed as mean±SD, NEFA levels are expressed as median (IQR), P value ≤0.05 is significance of difference. HDL‐c indicates high‐density lipoprotein cholesterol; HOMA‐IR, homeostatic model assessment of insulin resistance; LDL‐c, low‐density lipoprotein cholesterol; NEFA, nonesterified fatty acids; PCOS, polycystic ovary syndrome.